Vanguard Group Inc View Ray, Inc. Transaction History

Vanguard Group Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$0.35 - $3.28 $99,966 - $936,830	285,619 Added 2.79%	10,511,877 $3.68 Million
Q1 2023 May 15, 2023	BUY	$3.28 - $4.81 $318,665 - $467,310	97,154 Added 0.96%	10,226,258 $35.4 Million
Q4 2022 Feb 10, 2023	BUY	$3.65 - $4.82 $835,828 - $1.1 Million	228,994 Added 2.31%	10,129,104 $45.4 Million
Q3 2022 Nov 14, 2022	BUY	$2.66 - $3.97 $464,896 - $693,848	174,773 Added 1.8%	9,900,110 $36 Million
Q2 2022 Aug 12, 2022	BUY	$2.42 - $4.05 $2.11 Million - $3.54 Million	873,093 Added 9.86%	9,725,337 $25.8 Million
Q1 2022 May 13, 2022	BUY	$3.45 - $5.83 $2.39 Million - $4.03 Million	691,360 Added 8.47%	8,852,244 $34.7 Million
Q4 2021 Feb 14, 2022	BUY	$4.89 - $7.59 $1.58 Million - $2.45 Million	322,861 Added 4.12%	8,160,884 $45 Million
Q3 2021 Nov 12, 2021	BUY	$5.18 - $7.41 $5.72 Million - $8.19 Million	1,104,914 Added 16.41%	7,838,023 $56.5 Million
Q2 2021 Aug 13, 2021	BUY	$3.94 - $6.75 $26.5 Million - $45.4 Million	6,733,109 New	6,733,109 $44.4 Million

645K

50K

30K

Ticker VRAY
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 181,010,000
Market Cap $1.81M
Description
ViewRay, Inc. designs, manufactures, and markets magnetic resonance imaging (MRI) guided radiation therapy systems to image and treat cancer patients in the United States, France, Taiwan, the United Kingdom, and internationally. The company provides MRIdian, which is an MRI guided radiation therapy system that addresses beam distortion, skin tox...

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vanguard Group Inc with notifications on news.